Molecule Holdings Inc.
EVRRF · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Revenue | $2 | $0 | $0 | $0 |
| % Growth | 332.4% | – | – | – |
| Cost of Goods Sold | $3 | $1 | $0 | $0 |
| Gross Profit | -$1 | -$0 | -$0 | -$0 |
| % Margin | -54.6% | -109.8% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $2 | $2 | $1 |
| SG&A Expenses | $3 | $2 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $3 | $3 | $2 | $1 |
| Operating Income | -$4 | -$3 | -$2 | -$1 |
| % Margin | -198.9% | -701.1% | – | – |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | $0 |
| Pre-Tax Income | -$5 | -$4 | -$3 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$4 | -$3 | -$1 |
| % Margin | -230.8% | -928.6% | – | – |
| EPS | -0.047 | -0.046 | -0.026 | -0.24 |
| % Growth | -1.7% | -76.2% | 89.1% | – |
| EPS Diluted | -0.047 | -0.046 | -0.026 | -0.24 |
| Weighted Avg Shares Out | 97 | 92 | 76 | 5 |
| Weighted Avg Shares Out Dil | 97 | 92 | 76 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$3 | -$3 | -$3 | -$1 |
| % Margin | -165.5% | -631.5% | – | – |